Apotex is considering in which countries around the world it wishes to compete. Media reports have suggested the privately-owned Canadian generics firm – which has just revised its senior management team, putting president and chief operating officer Jeff Watson in charge of day-to-day operations (Generics bulletin, 2 February 2018, page 1) – is looking to divest its European business. India’s Aurobindo is rumoured to be interested.
Apotex assesses global presence
Apotex is considering in which countries around the world it wishes to compete. Media reports have suggested the privately-owned Canadian generics firm – which has just revised its senior management team, putting president and chief operating officer Jeff Watson in charge of day-to-day operations (Generics bulletin, 2 February 2018, page 1) – is looking to divest its European business. India’s Aurobindo is rumoured to be interested.